IDEX Corp. (IEX) delivered mixed results in Q2 FY2026 on revenue of $920.6M versus the $905.4M estimate (+6.4% YoY) and EPS of $2.32. The next IDEX Corp. (IEX) earnings date is Oct 28, 2026. Below is the full IDEX Corp. earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
IDEX Corp. (IEX) Earnings Analysis — key stats
Next earnings date
Oct 28, 2026
Latest reported quarter
Q2 FY2026
Earnings verdict
Mixed
EPS beat rate
6 of last 8 (quarters above estimate)
Avg next-day move
±6.3% (over the last 8 reports)
Post-earnings direction
Up 6 / Down 2 (of the last 8 reports)
Implied move (next report)
±8.8% (options-derived · into Oct 28, 2026)
Revenue
$920.6M (vs $905.4M est · +1.7% surprise · +6.4% YoY)
EPS
$2.32 (vs $2.11 est · +10.0% surprise · +11.5% YoY)
Share price
$233.69 (-0.3%)
Market cap
$17.2B
IDEX Corp. (IEX) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q3 FY2026
$920.6M vs $905.4M est
$2.32 vs $2.11 est
+10.0%
+4.1%
Mixed
Q2 FY2026
$886.9M vs $845.6M est
$2.00 vs $1.77 est
+13.0%
+6.1%
Beat
Q1 FY2026
$899.1M vs $882.3M est
$2.10 vs $2.04 est
+2.9%
+5.6%
Mixed
Q4 FY2025
$878.7M vs $861.4M est
$2.03 vs $1.93 est
+5.2%
+2.0%
Beat
Q3 FY2025
$865.4M vs $872.0M est
$2.07 vs $2.00 est
+3.5%
-11.7%
Mixed
Q2 FY2025
$814.3M vs $806.3M est
$1.75 vs $1.64 est
+6.7%
+4.3%
Mixed
Q1 FY2025
$862.9M vs $866.1M est
$2.04 vs $2.03 est
+0.5%
-9.7%
In line
Q4 FY2024
$798.2M vs $793.0M est
$1.90 vs $1.89 est
+0.5%
+6.7%
In line
What you'll find
Next IDEX Corp. (IEX) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment IDEX Corp. reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in IDEX Corp. (IEX)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is IDEX Corp.'s next earnings date?
IDEX Corp.'s (IEX) next scheduled earnings date is Oct 28, 2026. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did IDEX Corp. (IEX) beat or miss earnings?
In Q2 FY2026, IDEX Corp. (IEX) posted mixed results — revenue of $920.6M versus the $905.4M estimate (+1.7% surprise) and EPS of $2.32 versus $2.11 expected (+10.0% surprise). Magnisto decodes every IDEX Corp. (IEX) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does IDEX Corp. beat earnings estimates?
Over its last 8 reported quarters, IDEX Corp. (IEX) beat Wall Street EPS estimates 6 times, most recently a mixed result in Q3 FY2026. Magnisto tracks every IDEX Corp. (IEX) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does IDEX Corp. stock move after earnings?
Over its last 8 quarterly reports, IDEX Corp. (IEX) moved an average of ±6.3% the day after earnings — ranging from -11.7% (Q3 FY2025) to +6.7% (Q4 FY2024). The stock rose after 6 of those 8 reports and fell after 2. Heading into its next report on Oct 28, 2026, options-implied volatility is pricing in a move of roughly ±8.8% (derived). Magnisto tracks the realized post-earnings move for every IDEX Corp. (IEX) quarter alongside the beat/miss verdict — past moves don't predict the next one.
What is the forecast for IDEX Corp. (IEX) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for IDEX Corp. (IEX), anchored to the current $233.69 share price, so you can weigh the bull, base and bear cases for IDEX Corp. side by side.
Is IDEX Corp. (IEX) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether IDEX Corp. fits your own thesis and risk profile. This is research, not investment advice.